Progentos Therapeutics Appoints Andrew Miller, Ph.D. to Chairman of its Board of Directors October 2, 2024
Be Biopharma Announces Preclinical Data for Novel Engineered B Cell Medicine for the Potential Treatment of Hypophosphatasia September 30, 2024
Longwood Healthcare Leaders’ Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research September 24, 2024
Engrail Therapeutics Initiates ENX-104 Clinical Program for the Treatment of Major Depressive Disorder Characterized by Anhedonia September 18, 2024
AAVantgarde Announces First Patient Dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 Study for Retinitis Pigmentosa Related to USH1B September 16, 2024